BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32976747)

  • 1. Routine haematological parameters in COVID-19 prognosis.
    Pereyra D; Heber S; Jilma B; Zoufaly A; Assinger A
    Lancet Haematol; 2020 Oct; 7(10):e709. PubMed ID: 32976747
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 and haematological malignancy: navigating a narrow strait.
    Rubinstein SM; Warner JL
    Lancet Haematol; 2020 Oct; 7(10):e701-e703. PubMed ID: 32798474
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation disorder in COVID-19.
    Kander T
    Lancet Haematol; 2020 Sep; 7(9):e630-e632. PubMed ID: 32659213
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum ferritin as an independent risk factor for severity in COVID-19 patients.
    Lin Z; Long F; Yang Y; Chen X; Xu L; Yang M
    J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32592705
    [No Abstract]   [Full Text] [Related]  

  • 5. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.
    Giusti B; Gori AM; Alessi M; Rogolino A; Lotti E; Poli D; Sticchi E; Bartoloni A; Morettini A; Nozzoli C; Peris A; Pieralli F; Poggesi L; Marchionni N; Marcucci R
    Thromb Haemost; 2020 Aug; 120(8):1233-1236. PubMed ID: 32455440
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral aetiology and clinical characteristics of acute respiratory tract infections in Shenzhen during epidemic of coronavirus disease 2019.
    Zhang D; Jiang Y; Hua J; Liu Q; Wen W; Zhu M; Du J; Liu H
    Infect Dis (Lond); 2020 Aug; 52(8):590-592. PubMed ID: 32452728
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?
    Conti CB; Henchi S; Coppeta GP; Testa S; Grassia R
    Eur J Intern Med; 2020 Jul; 77():147-149. PubMed ID: 32414639
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19: associated morbidity and mitigation strategies.
    Mahmood SN; Woods CJ; Chan CM
    Infect Dis (Lond); 2020; 52(12):923-926. PubMed ID: 32726166
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 Coagulopathy: Considerations for Urologists.
    Jue JS; Alameddine M
    J Urol; 2020 Oct; 204(4):640-641. PubMed ID: 32648819
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.
    Pallotto C; Suardi LR; Esperti S; Tarquini R; Grifoni E; Meini S; Valoriani A; Di Martino S; Cei F; Sisti E; Piani F; Botta A; Salomoni E; Baragli F; Blanc P
    Infect Dis (Lond); 2020 Sep; 52(9):675-677. PubMed ID: 32543971
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulation in COVID-19.
    Atallah B; Mallah SI; AlMahmeed W
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):260-261. PubMed ID: 32352517
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulation profile in severe COVID-19 patients: what do we know so far?
    Savioli F; Rocha LL
    Rev Bras Ter Intensiva; 2020 Jun; 32(2):197-199. PubMed ID: 32667446
    [No Abstract]   [Full Text] [Related]  

  • 13. Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.
    Pirola CJ; Sookoian S
    J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32407757
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory abnormalities related to prolonged hospitalization in COVID-19.
    Tezcan ME; Doğan Gökçe G; Ozer RS
    Infect Dis (Lond); 2020 Sep; 52(9):666-668. PubMed ID: 32543300
    [No Abstract]   [Full Text] [Related]  

  • 15. A familial cluster of severe coronavirus disease 2019 that required intubation of all family members.
    Katsuno T; Suzuki M; Ishikane M; Kinoshita N; Tsukada A; Morita C; Kusaba Y; Sakamoto K; Yamaguchi Y; Tsujimoto Y; Hashimoto M; Terada J; Takasaki J; Izumi S; Okuhama A; Ide S; Moriyama Y; Matsuda K; Takamatsu Y; Mitsuya H; Hojo M; Sugiyama H
    Infect Dis (Lond); 2020 Oct; 52(10):755-758. PubMed ID: 32615051
    [No Abstract]   [Full Text] [Related]  

  • 16. Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity - diabetes?
    Pontiroli AE; La Sala L; Chiumello D; Folli F
    Diabetes Res Clin Pract; 2020 Sep; 167():108342. PubMed ID: 32730788
    [No Abstract]   [Full Text] [Related]  

  • 17. Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?
    Sanchis-Gomar F; Perez-Quilis C; Lavie CJ
    Eur Heart J; 2020 Jul; 41(32):3092-3093. PubMed ID: 32688380
    [No Abstract]   [Full Text] [Related]  

  • 18. Tocilizumab for COVID-19: a real 'miracle drug'?
    Nasim S; Hashmi SH; Azim D; Kumar S; Nasim J
    Infect Dis (Lond); 2020 Sep; 52(9):681-682. PubMed ID: 32644027
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac injury and mortality in COVID-19: A reappraisal.
    Vrsalovic M; Presecki AV
    J Infect; 2020 Sep; 81(3):e35-e36. PubMed ID: 32615200
    [No Abstract]   [Full Text] [Related]  

  • 20. Predominance of hospital-acquired bloodstream infection in patients with Covid-19 pneumonia.
    Engsbro AL; Israelsen SB; Pedersen M; Tingsgaard S; Lisby G; Andersen CØ; Benfield T
    Infect Dis (Lond); 2020; 52(12):919-922. PubMed ID: 32779951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.